Blog

featured image of Techbio Startup AMPLY Gets £14m to Fight Complex Diseases

Techbio Startup AMPLY Gets £14m to Fight Complex Diseases

BIOT

1. 🎉 Belfast's AMPLY Discovery Ltd secures £1.4m funding to combat complex diseases through AI-powered drug discovery! 💪🔬🌱 2. AMPLY Discovery Ltd: Revolutionizing drug discovery with AI and synthetic biology to combat genetic cancers and drug-resistant lung infections. 💊💡💪

featured image of Novartis Boosts Portfolio with Monjuvi Acquisition

Novartis Boosts Portfolio with Monjuvi Acquisition

BIOT

📰 Novartis acquires MorphoSys, gaining access to Monjuvi for lymphoma treatment. 🤝 Strengthens portfolio, expands biotech presence. 😊 Incyte benefits from collaboration agreement. 💼 Reflects global biotech growth.

featured image of Samsung Biologics and LegoChem unite to revolutionize cancer treatment

Samsung Biologics and LegoChem unite to revolutionize cancer treatment

BIOT

🔍 Samsung Biologics teams up with LegoChem to advance ADCs, combining antibodies and drugs to target cancer cells. 🔬 Collaboration leverages manufacturing expertise and ADC development technology for better cancer treatment options.

featured image of BioNTech and Autolus Join Forces for Revolutionary Cancer Treatments

BioNTech and Autolus Join Forces for Revolutionary Cancer Treatments

BIOT

📢 BioNTech and Autolus join forces in a $250m deal to revolutionize CAR-T cell therapies for cancer treatment. 💼🔬💪

featured image of Revolutionary Partnership Speeds Up mRNA Analysis!

Revolutionary Partnership Speeds Up mRNA Analysis!

BIOT

🧪📈 Lonza and Oxford Nanopore join forces to revolutionize mRNA analysis in the fast-paced biotech sector. Exciting times ahead!

featured image of Gene Therapy Breakthrough Acquisition and Bankruptcy Shake Biotech Industry!

Gene Therapy Breakthrough Acquisition and Bankruptcy Shake Biotech Industry!

BIOT

📰 Intellia and Ultragenyx's clinical updates, Novo Holdings' Catalent acquisition, and NanoString bankruptcy; Simon Barnett 💊💼💥💡

featured image of Cambridge Start-Up Bags £225m for Carbon-Negative Biofuel

Cambridge Start-Up Bags £225m for Carbon-Negative Biofuel

BIOT

🌿 British-Malasian marine algae start-up, HutanBio, bags £2.25m seed financing to produce carbon-negative biodiesel. 🌊💰

featured image of Discover the Versatile Marvel of Albumin

Discover the Versatile Marvel of Albumin

BIOT

💪 Albumin plays a crucial role in the body, from maintaining osmotic pressure to transporting molecules and preventing oxidative damage. 🔬 💊 Its diverse uses in pharmaceuticals, vaccine production, and biomedical coatings make it a valuable resource. 💡 🌍 The global albumin market is expanding, with recombinant albumins leading the way in medical applications. 📈

featured image of Revolutionary Detergent Boosts Virus Clearance in Biopharmaceuticals

Revolutionary Detergent Boosts Virus Clearance in Biopharmaceuticals

BIOT

📰 Enhancing Virus Clearance Process Capability Using a Biodegradable Detergent explores how a biodegradable detergent improves virus clearance in biopharmaceutical manufacturing processes. 💡

featured image of Game-Changing Novo Catalent Deal Revolutionizes CGT Outsourcing

Game-Changing Novo Catalent Deal Revolutionizes CGT Outsourcing

BIOT

📢 Get ready for a game-changer! The Novo Catalent deal is about to shake up the CGT outsourcing space. 💥🧪💼